| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |